Patent · US Active

Immune stimulating compound

US11059846B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) · SE

Inventors

Ola Winqvist · Uppsala, SE
Emma Lindh · Knivsta, SE
Robert Wallin · Bålsta, SE
Matt Gregory · Cambridge, GB
Steven Moss · Balsham, GB

Key dates

Filing date	Feb 22, 2018
Grant date	Jul 13, 2021
Priority date	—
Expiry date	Feb 22, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating intracellular bacterial, fungal, and protozoal infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.